Location History:
- Karnataka, IN (2017)
- Bengaluru, IN (2018)
- Raichur, IN (2018 - 2020)
Company Filing History:
5 out of 3,685 
1 out of 13 Years Active: 2017-2020
Title: The Innovative Journey of Sharanabasappa Patil
Introduction
Sharanabasappa Patil, a notable inventor based in Raichur, India, has made significant contributions to the field of pharmaceuticals with five patents to his name. His work focuses primarily on developing innovative compounds that target various medical conditions, showcasing his commitment to advancing healthcare through research and innovation.
Latest Patents
Among his latest inventions are two remarkable patents involving spiro-fused cyclic ureas as selective ROCK inhibitors. The first patent presents compounds of a specific formula, which include stereoisomers and pharmaceutically acceptable salts. This invention not only describes the compounds but also outlines their application in treating diverse disorders, including cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and inflammatory conditions. The second patent mirrors the first in its focus on cyclic ureas as ROCK inhibitors, emphasizing the potential for pharmaceutical compositions derived from these compounds to address significant health issues effectively.
Career Highlights
Sharanabasappa has built his career by working with esteemed organizations such as Bristol-Myers Squibb Company and Exelixis Patent Company LLC. His experiences at these companies have enabled him to gain extensive knowledge and expertise in the pharmaceutical field, further enhancing his ability to innovate and contribute valuable inventions.
Collaborations
Throughout his career, Sharanabasappa has collaborated with talented individuals such as Mandar Shrikrishna Bodas and Peter W. Glunz. These partnerships have likely enriched his work, allowing for a fusion of ideas and expertise that propel innovation forward.
Conclusion
Sharanabasappa Patil stands out as an inspiring inventor in the pharmaceutical industry. With his five patents, particularly in the development of ROCK inhibitors, he demonstrates a passionate dedication to improving health outcomes through innovative solutions. His collaborations and experiences at leading companies underline the importance of teamwork and knowledge-sharing in fostering innovation.